Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1999
10/12/1999US5965367 Purified bradykinin B1 receptor
10/12/1999US5965175 Feeding a dog a diet of pet food containing fermentable fibers having an organic matter disappearance of 15-60% when fermented by fecal bacteria for 24 hours, the fibers being present in amounts of 1-11%; increased elimination
10/12/1999US5965157 Method to provide for production of hair coloring pigments in hair follicles
10/12/1999US5965119 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/12/1999US5964224 Method for treating amyotrophic lateral sclerosis and a therapeutic agent therefor
10/07/1999WO1999050413A2 THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY
10/07/1999WO1999050403A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999WO1999050276A1 3',3'-n-bis-substituted macrolide lhrh antagonists
10/07/1999WO1999050275A2 Macrolide lhrh antagonists
10/07/1999WO1999050272A1 Phosphinic acid derivatives
10/07/1999WO1999050269A2 Porphyrins and their use as photosensitizer
10/07/1999WO1999050268A2 Substituted indolealkanoic acids
10/07/1999WO1999050263A1 Quinolones as serine protease inhibitors
10/07/1999WO1999050262A1 Pde iv inhibiting pyridine derivatives
10/07/1999WO1999050257A1 Benzoxazinones/benzothiazinones as serine protease inhibitors
10/07/1999WO1999050255A2 Disubstituted pyrazolines and triazolines as factor xa inhibitors
10/07/1999WO1999050254A1 Quinoxalinones as serine protease inhibitors such as factor xa and thrombin
10/07/1999WO1999050253A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
10/07/1999WO1999050252A2 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
10/07/1999WO1999050251A2 Cyclin dependent kinase inhibitors
10/07/1999WO1999050249A2 Pyrimidines and triazines as integrin antagonists
10/07/1999WO1999050247A1 Compounds with activity on muscarinic receptors
10/07/1999WO1999050230A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
10/07/1999WO1999049909A2 Revascularization apparatus having coaxial channeling and injecting means
10/07/1999WO1999049887A1 Use of protease inhibitors for treating skin wounds
10/07/1999WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999WO1999049884A1 A method for the prevention of a patient's fibroproliferative vasculopathy
10/07/1999WO1999049881A2 Application of hsp70 proteins
10/07/1999WO1999049871A1 Method of inhibiting membrane-type matrix metalloproteinase
10/07/1999WO1999049864A1 Indole-2,3-dione-3-oxime derivatives for therapeutic use
10/07/1999WO1999049856A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999WO1999049855A2 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
10/07/1999WO1999049854A2 Use of dexmedetomidine for icu sedation
10/07/1999WO1999049852A1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
10/07/1999WO1999049734A1 Method of inhibiting immune system destruction of transplanted viable cells
10/07/1999WO1999042456A3 Novel compounds and their use as positive ampa receptor modulators
10/07/1999WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999WO1999030720A9 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/07/1999DE19901270A1 Production of beta-1,6-branched beta-1,3-glucan useful as skin anti-aging, depigmenting and healing agent
10/07/1999DE19815411A1 Thermogenesis stimulant comprising moxonidine, useful e.g. for treating hypothermia or promoting weight loss, having no cardiac stimulant side effects
10/07/1999DE19814405A1 Neue Porphyrine und ihre Verwendung New porphyrins and their use
10/07/1999DE19814358A1 Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn Use of alkyl hydrogen for the treatment of psoriasis, psoriatic arthritis, atopic dermatitis, and Crohn's disease
10/07/1999DE19813760A1 Activation of natural killer cells to stimulate immune response, especially in treatment of tumors, infections and autoimmune diseases
10/07/1999CA2333927A1 Pyrimidines and triazines as integrin antagonists
10/07/1999CA2326576A1 Indole-2,3-dione-3-oxime derivatives for therapeutic use
10/07/1999CA2326438A1 Use of protease inhibitors for treating skin wounds
10/07/1999CA2326357A1 Cyclin dependent kinase inhibitors
10/07/1999CA2325986A1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999CA2325735A1 Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation
10/07/1999CA2325521A1 Macrolide lhrh antagonists
10/07/1999CA2325519A1 3',3'-n-bis-substituted macrolide lhrh antagonists
10/07/1999CA2324584A1 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
10/07/1999CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
10/07/1999CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999CA2323748A1 A method for the prevention of a patient's fibroproliferative vasculopathy
10/07/1999CA2322203A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
10/07/1999CA2321538A1 Disubstituted pyrazolines and triazolines as factor xa inhibitors
10/07/1999CA2320260A1 Method of inhibiting membrane-type matrix metalloproteinase
10/07/1999CA2319588A1 Materials and methods relating to the treatment of conditions involving mast cells basophils and eosinophils
10/07/1999CA2319551A1 Benzoxazinones/benzothiazinones as serine protease inhibitors
10/07/1999CA2312953A1 Quinolones as serine protease inhibitors
10/07/1999CA2290363A1 Method of inhibiting immune system destruction of transplanted viable cells
10/06/1999EP0947523A1 Acyl derivatives of glycosyl-L-ascorbic acid
10/06/1999EP0947511A1 Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
10/06/1999EP0947506A1 2-Aza-bicyclo[2.2.1]heptane derivatives and their use as rotamase inhibitors
10/06/1999EP0947503A1 6,8-Dimethylmercaptooctanoic acid derivatives substituted on 6-S and/or 8-S by the 3-methylthiopropanoyl radical and pharmaceutical compositions for the treatment of cancerous tumours
10/06/1999EP0946728A1 Bone stimulating factor
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946715A1 Modified protein c and methods of use thereof
10/06/1999EP0946589A1 Inhibitors of peptide binding to mhc class ii proteins
10/06/1999EP0946588A1 Use of dipeptide derivatives
10/06/1999EP0946587A2 New amide compounds
10/06/1999EP0946584A1 Meiosis regulating compounds
10/06/1999EP0946568A1 Use of 7-alkylidene cephalosporins to inhibit elastase activity
10/06/1999EP0946566A1 Pro-drugs and counterparts of camptothecin, their application as medicines
10/06/1999EP0946561A1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments
10/06/1999EP0946555A1 Pyrrole derivatives, their preparation and pharmaceutical compositions containing them
10/06/1999EP0946554A1 Fused bicyclic pyrimidine derivatives
10/06/1999EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/06/1999EP0946548A1 Novel heterocyclic substituted pyrrolidine amide derivatives
10/06/1999EP0946546A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
10/06/1999EP0946542A1 Indane or dihydroindole derivatives
10/06/1999EP0946541A1 Quinolines and their therapeutic use
10/06/1999EP0946539A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
10/06/1999EP0946528A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
10/06/1999EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity
10/06/1999EP0946518A1 Modulators of proteins with phosphotyrosine recognition units
10/06/1999EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999EP0946509A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
10/06/1999EP0946508A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS
10/06/1999EP0946503A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
10/06/1999EP0946502A1 Sulfonamide interleukin-beta converting enzyme inhibitors
10/06/1999EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
10/06/1999EP0946189A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
10/06/1999EP0946186A1 Stomach submucosa derived tissue graft
10/06/1999EP0946177A1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A
10/06/1999EP0946173A1 Preparation of 3-fluoro oxindole derivatives
10/06/1999EP0946172A1 Method for inhibiting stress-activated protein kinases
10/06/1999EP0946170A1 Inhibition of protein glycation and prevention of vasculopathy
10/06/1999EP0946165A1 Integrin antagonists
1 ... 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 ... 1564